How many milliliters of the oral valproic acid solution (250 mg per 5 mL) are equivalent to a 250 mg tablet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Valproic Acid Oral Solution Dosing Equivalence

5 mL of the oral valproic acid solution (250 mg/5 mL) is equivalent to one 250 mg tablet.

Direct Calculation

The concentration of the oral solution is 250 mg per 5 mL, which means:

  • 250 mg ÷ 5 mL = 50 mg/mL
  • To deliver 250 mg: 250 mg ÷ 50 mg/mL = 5 mL

Bioavailability Considerations

  • Valproic acid oral formulations (solutions, tablets, enteric-coated capsules) have bioavailability approaching 100%, making them therapeutically equivalent on a milligram-per-milligram basis 1
  • The primary difference between formulations is the absorption half-life, which varies from less than 30 minutes for solutions to 3-4 hours for enteric-coated preparations, but this does not affect total drug delivery 1

Clinical Context

  • Once absorbed, valproic acid has a relatively small volume of distribution (0.1-0.4 L/kg) and is largely bound to plasma proteins, with therapeutic plasma concentrations typically ranging from 50-100 mg/L 1, 2
  • The half-life in adults varies from 10-20 hours, while it is significantly shorter (6-9 hours) in children, which affects dosing frequency but not individual dose equivalence 1

Important Formulation Note

  • Do not assume that two 250 mg tablets equal one 500 mg tablet for combination products (such as amoxicillin-clavulanic acid formulations where clavulanic acid content differs), though this caveat does not apply to single-ingredient valproic acid products 3

References

Research

Clinical pharmacokinetics of valproic acid--1988.

Clinical pharmacokinetics, 1988

Research

Concentration-effect relationships of valproic acid.

Clinical pharmacokinetics, 1985

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.